Beta Bionics

Beta Bionics

Early Stage

Building a bionic pancreas to improve the lives of people with type 1 diabetes

Building a bionic pancreas to improve the lives of people with type 1 diabetes

Overview

Funding data not publicly available
Platform

Self Managed

Start Date

07/01/2019

Close Date

07/22/2019

Max. Goal
$63,360,000
Min. Investment

$0

Security Type

Equity - Common

SEC Filing Type

RegD 506(b)    Open SEC Filing

Year Founded

2015

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

Boston, Massachusetts

Beta Bionics is raising funds independently via Reg D 506(b) raise. The company has developed effective diabetes management solutions to facilitate people with diabetes and their caregivers. Beta Bionics has received FDA clearance for the first and only automated insulin-delivery system, iLet Bionic Pancreas, that determines 100% of all insulin doses. The system only needs the patient’s body weight to get started and does not involve carb counting, corrections, or calculating boluses. Ed Damiano founded Beta Bionics in 2015. The current crowdfunding campaign has a maximum target of $63.36 million. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to Kingscrowd analytics.

Raise History

Offering Name Close Date Platform Valuation Total Raised Security Type Status Reg Type
Beta Bionics 08/30/2023 Self Managed - - Other Security Type Funded RegD 506(c)
Beta Bionics 03/02/2022 Self Managed - - Equity - Common Funded RegD 506(b)
Beta Bionics 07/22/2019 Self Managed - - Equity - Common Funded RegD 506(b)
Beta Bionics 12/27/2017 Self Managed - - Equity - Common Funded RegD 506(b)
Beta Bionics 08/29/2016 Wefunder $100,000,000 $1,000,000 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Beta Bionics on Self Managed 2019
Platform: Self Managed
Security Type: Equity - Common

Follow company

Follow Beta Bionics on Self Managed 2019
No Public Offering Page

Buy Beta Bionics's Deal Report

Warning: according to the close date for this deal, Beta Bionics may no longer be accepting investments.

Beta Bionics Deal Report

Get Kingscrowd's comprehensive report on Beta Bionics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Beta Bionics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Beta Bionics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge